| 摘要 |
The present invention relates to anti-GM-CSF antagonists in the treatment and prevention of infections caused by agents inducing hemorrhagic fever, such as Ebola viruses. The invention also relates to pharmaceutical compositions comprising such antagonists, which are preferably anti-GM-CSF antibodies. |
